Olmutinib hydrochloride is the hydrochloride salt form of olmutinib, an orally available small molecule that selectively inhibits mutant forms of epidermal growth factor receptor (EGFR). It is primarily used as an active pharmaceutical ingredient in research and manufacturing contexts.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1842366-97-5
(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)acetic acid--piperazine (2/1)
pharmaceutical raw material
Gefitinib
pharmaceutical raw material
Cofrogliptin
pharmaceutical raw material
6beta-methylprednisolone
pharmaceutical raw material
N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;dihydrochloride
KIHHNWDWKMJZHH-UHFFFAOYSA-N
CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4.Cl.Cl